ValuentumAd

Official PayPal Seal














Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 20, 2012
Aetna Nabs Coventry
Consolidation continues in the health insurer space, as Aetna acquires Coventry, a company leveraged to Medicaid.
Aug 17, 2012
The Gap is Back…But We’re Not Chasing It Here
Gap continues to post excellent results, but we think the stock price is now way ahead of its fundamentals.
Aug 17, 2012
Is Sears the Ultimate Value Stock?
We don't think so, but we assess the retailer after its weak second quarter results and bullish commentary from Bruce Berkowitz.
Aug 17, 2012
Our Outlook for the Market
President of Equity Research & ETF Analysis, Brian Nelson offers insight into Valuentum's outlook for the market.
Aug 17, 2012
Wal-Mart Keeps Rolling
After struggling in 2010, Wal-Mart is back on track. Still, we think shares are fairly valued.
Aug 16, 2012
Ross Stores Posts A Strong Second Quarter
Discounter Ross Stores posted strong second-quarter results, but shares are too rich for our liking.
Aug 16, 2012
Cisco Makes Itself a True Income Investment
In addition to reporting strong earnings, Cisco boosted its dividend 75% to give it a meaningful yield.
Aug 16, 2012
Hedge Fund Manager Bets Big on Health Insurers
Hedge fund manager David Einhorn established positions in several large health insurers. We like the move, but prefer the Healthcare Select Sector SPDR (XLV).
Aug 16, 2012
Target Remains Strong; Posts Solid Second Quarter Results
Retail giant Target continues to post strong results, in spite of macro headwinds. We think shares are fairly valued at this time.
Aug 16, 2012
Deere Misses Its Own Forecast
Agricultural equipment maker Deere reported weaker than expected results for its third quarter. Shares are fairly valued, but we could become interested if weakness continues.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.